ServiceNow (NOW) Q1 2026 Earnings Meet Estimates; Armis Deal Weighs on Margin Outlook
Alpha Stocks Insight Staff
Independent stock news and analysis covering NASDAQ and NYSE markets.
ServiceNow reported Q1 results in line with estimates, but shares fell as an Armis acquisition clouded the near-term margin picture.
NYSE: NOW · April 22, 2026 · 3 min read
ServiceNow (NYSE: NOW) reported first-quarter 2026 results that met Wall Street's earnings expectations while revenue edged past estimates — yet the stock fell following the release, as the company's newly announced agreement with Armis raised questions about the near-term margin trajectory. The April 22, 2026 SEC 8-K filing confirmed both a material definitive agreement — consistent with the Armis deal — and an earnings release under the same submission.
Q1 2026 At a Glance
- Current price: $103.07, up $2.93 (+2.93%) on the day; prior close $100.14
- 52-week range: $81.24 – $211.48, highlighting the stock's significant drawdown from recent highs
- Market cap: $107.8 billion
- Trailing P/E: 61.7x | Forward P/E: 20.5x
- Revenue growth (YoY): 20.7%
- Earnings growth (YoY): 3.4%
- Gross margin: 77.5% | Operating margin: 16.5% | Net margin: 13.2%
What Drove the Results
ServiceNow's top-line momentum remained intact, with 20.7% year-over-year revenue growth reflecting continued enterprise demand for its AI-enabled workflow platform. The company's 77.5% gross margin underscores the inherent profitability of its software business, though the comparatively modest 16.5% operating margin and 3.4% earnings growth suggest that investment in AI capabilities and platform expansion is absorbing a meaningful share of incremental revenue.
The Armis deal — a material definitive agreement filed with the SEC on April 22 — appears to be the primary reason the market reacted cautiously despite the in-line print. Investors are weighing integration costs and potential dilution to margins at a time when earnings growth is already running well below revenue growth. Separately, TridentCare announced a strategic partnership with (NYSE: NOW) to deploy its AI platform across portable diagnostics operations, adding a concrete commercial validation of the platform's reach into healthcare services.
Wall Street View
Analyst sentiment toward (NYSE: NOW) remains firmly constructive. As of April 1, 2026, the consensus stood at 15 Strong Buy, 32 Buy, 4 Hold, and just 1 Sell — a distribution that was unchanged from the prior month's survey on March 1, 2026. The absence of any rating deterioration heading into the earnings report suggests the Street views the Armis-related margin pressure as a transitory concern rather than a structural one.
Investor Takeaway
ServiceNow delivered a quarter that was broadly consistent with expectations, and the analyst community has not shifted its predominantly bullish stance despite the post-earnings decline. The key variable for investors to monitor is how the Armis integration affects operating margins over the coming quarters, given that earnings growth at 3.4% is already lagging well behind revenue expansion of 20.7%. The forward P/E of 20.5x — a steep discount to the trailing multiple of 61.7x — implies the market is pricing in a meaningful acceleration in earnings, making margin execution the central story from here.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.